Safety profile and clinical activity of sifalimumab, a fully human anti-interferon   monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study

Details 詳細情報について

• CRID

  1362262945702471168

• DOI

  10.1136/ard.2010.144485

• ISSN

  00034967

• Web Site

  https://syndication.highwire.org/content/doi/10.1136/ard.2010.144485

• Data Source

  • Crossref